What is Catalog Technologies?
Catalog Technologies is pioneering the integration of DNA into algorithms and applications through a proprietary data encoding scheme. The company's core innovation lies in its ability to leverage biological material for digital information storage, offering a potentially revolutionary solution for long-term, high-density data archiving. This technology positions Catalog Technologies at the intersection of biotechnology and information technology, addressing the ever-increasing demand for scalable and durable data storage.
How much funding has Catalog Technologies raised?
Catalog Technologies has raised a total of $50M across 3 funding rounds:
Angel/Seed
$5M
Series A
$10M
Series B
$35M
Angel/Seed (2017): $5M with participation from OS Fund, Wilson Sonsini, StarVest Partners, IndieBio, Kauffman Fellows, SOSV, New Enterprise Associates, Industry Ventures, Starlight Ventures, and Pathbreaker Ventures
Series A (2020): $10M led by Airbus Ventures and Horizons Ventures
Series B (2021): $35M supported by Hanwha Impact
Key Investors in Catalog Technologies
Airbus Ventures
Airbus Ventures is a venture capital firm that invests in deeptech entrepreneurs focused on enhancing the planet's future, with an emphasis on unlocking the hypersonic economy and harnessing space resources. They provide growth capital and support for innovative technologies.
Hanwha Impact
Hanwha Impact is an entity involved in strategic investments, contributing to the financial backing of companies within its investment focus. Specific details on their investment specialization are not provided, but their participation indicates a strategic interest in Catalog Technologies' sector.
OS Fund
OS Fund invests in entrepreneurs commercializing breakthrough discoveries in genomics, synthetic biology, and advanced materials, aiming to create a better future through visionary ventures.
What's next for Catalog Technologies?
With its recent major strategic investment, Catalog Technologies is poised to accelerate its development and market penetration. The substantial capital infusion, reflected in the $50M, suggests a move towards scaling operations, further refining its DNA data encoding technology, and potentially expanding its application into enterprise-level data management solutions. This strategic financing is expected to fuel innovation and solidify its position as a leader in the emerging field of DNA data storage, enabling the company to explore new frontiers in digital information preservation.
See full Catalog Technologies company page
